HAP Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HAP Trading’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$11.3K	Sell	10,500 -8,600	-45%	-$775K	﹤0.01%	760
2025 Q2	$68.1K	Buy	19,100 +5,000	+35%	+$399K	0.01%	475
2025 Q1	$94.8K	Sell	14,100 -10,800	-43%	-$965K	0.01%	402
2024 Q4	$138K	Sell	24,900 -5,500	-18%	-$533K	0.01%	358
2024 Q3	$54.3K	Sell	30,400 -32,000	-51%	-$3.14M	0.01%	465
2024 Q2	$313K	Buy	62,400 +28,000	+81%	+$2.51M	0.04%	240
2024 Q1	$253K	Sell	34,400 -4,700	-12%	-$436K	0.03%	267
2023 Q4	$407K	Sell	39,100 -27,200	-41%	-$2.02M	0.06%	216
2023 Q3	$57.6K	Buy	+66,300	New	+$5.3M	0.01%	477
2023 Q2	–	Sell	-519,000	Closed	-$895K	–	1404
2023 Q1	$895K	Buy	519,000 +487,700	+1,558%	+$40.5M	0.14%	142
2022 Q4	$53K	Sell	31,300 -33,000	-51%	-$2.67M	0.01%	726
2022 Q3	$1.27M	Sell	64,300 -204,600	-76%	-$17.2M	0.08%	211
2022 Q2	$2.07M	Sell	268,900 -92,800	-26%	-$6.97M	0.1%	171
2022 Q1	$1.26M	Sell	361,700 -409,200	-53%	-$37.8M	0.05%	298
2021 Q4	$5.95M	Buy	770,900 +197,300	+34%	+$23.8M	0.16%	109
2021 Q3	$3.36M	Buy	573,600 +139,800	+32%	+$18M	0.11%	184
2021 Q2	$296K	Buy	+433,800	New	+$57M	0.01%	838
2021 Q1	–	Sell	-524,500	Closed	-$286K	–	2586
2020 Q4	$286K	Buy	+524,500	New	+$67.2M	0.01%	837
2019 Q3	–	Sell	-319,800	Closed	-$1.17M	–	1477
2019 Q2	$1.17M	Sell	319,800 -92,200	-22%	-$7.86M	0.09%	184
2019 Q1	$864K	Sell	412,000 -815,900	-66%	-$69.4M	0.08%	205
2018 Q4	$4.41M	Buy	1,227,900 +889,900	+263%	+$71.7M	0.28%	70
2018 Q3	$381K	Sell	338,000 -861,600	-72%	-$83.5M	0.02%	335
2018 Q2	$1.63M	Sell	1,199,600 -413,700	-26%	-$38M	0.08%	175
2018 Q1	$4.3M	Buy	1,613,300 +569,100	+55%	+$52M	0.22%	73
2017 Q4	$1.01M	Buy	1,044,200 +648,400	+164%	+$54.3M	0.04%	276
2017 Q3	$290K	Buy	395,800 +169,600	+75%	+$13.6M	0.01%	451
2017 Q2	$208K	Sell	226,200 -380,100	-63%	-$27M	0.01%	508
2017 Q1	$964K	Sell	606,300 -54,300	-8%	-$3.65M	0.06%	238
2016 Q4	$550K	Sell	660,600 -298,100	-31%	-$18.4M	0.03%	334
2016 Q3	$473K	Buy	+958,700	New	+$59.3M	0.02%	377
2016 Q2	–	Sell	-170,000	Closed	-$145K	–	1059
2016 Q1	$145K	Sell	170,000 -615,000	-78%	-$31.9M	0.01%	421
2015 Q4	$1.3M	Sell	785,000 -81,700	-9%	-$5.57M	0.06%	238
2015 Q3	$3.23M	Sell	866,700 -1,730,100	-67%	-$136M	0.17%	132
2015 Q2	$929K	Buy	2,596,800 +1,345,200	+107%	+$105M	0.06%	271
2015 Q1	$1.69M	Buy	+1,251,600	New	+$87.4M	0.11%	174
2014 Q4	–	Sell	-600,000	Closed	-$545K	–	1237
2014 Q3	$545K	Buy	+600,000	New	+$30.6M	0.02%	450
2014 Q2	–	Sell	-285,000	Closed	-$247K	–	1184
2014 Q1	$247K	Buy	+285,000	New	+$14.6M	0.01%	578

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

HAP Trading's XBI Position: Q2 2024 in Review

HAP Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 12,535 shares — an estimated $1.12M sold.

HAP Trading first reported a position in XBI in Q3 2015 and held it in 8 quarters. The position peaked at $60.9M in Q4 2021. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

HAP Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
HAP Trading sold 12,535 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $1.12M.
HAP Trading first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 8 quarters.
HAP Trading's State Street SPDR S&P Biotech ETF position peaked at $60.9M in Q4 2021.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on HAP Trading's 13F filing for Q2 2024, filed 14 Aug 2024.